UNLIMITED TURBO LONG - VIRBAC | Market Closed - Euronext Paris 17:30:02 17/05/2024 BST | ||
| 0.91 EUR | -5.21% |
|
| Current month | +7.06% | ||
| 1 month | -15.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
VIRBAC
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 0.91 | -5.21% |
| 16/05/24 | 0.96 | -7.69% |
| 15/05/24 | 1.04 | +0.97% |
| 14/05/24 | 1.03 | +7.29% |
| 13/05/24 | 0.96 | +2.13% |
Real-time Euronext Paris
Last update May 17, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIRBAC |
| Issuer | 
BNP Paribas
|
| CN9MB | |
| ISIN | FRBNPP068YL6 |
| Date issued | 07/12/2023 |
| Strike | 274.2 € |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.29 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.145 € |
|---|---|
| Lowest since issue | 0.345 € |
Company Profile
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families:
- pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
Consensus: Virbac
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
359.5
EUR
Average target price
372.4
EUR
Spread / Average Target
+3.60%
- Stock Market
- Certificates
- CN9MB Certificat
